GLP-1 weight-loss drugs like Ozempic, Wegovy, and Mounjaro are facing thousands of lawsuits over serious side effects, framed here as bad news for users chasing quick weight loss.

• About 31 million Americans are now taking GLP-1 drugs, and 4,400 US lawsuits have already been filed.
• Reported side effects include sudden blindness, stomach paralysis, dead intestines, organ failure, and some deaths.
• Rapid weight loss causes "Ozempic face" — hollow cheeks and sagging skin — plus bone loss severe enough to give people in their 30s elderly-level bone density.
• Most of the weight lost is muscle, not fat, leaving users lighter but weaker and more frail.
• The FDA is accusing Novo Nordisk of underreporting serious side effects and deaths tied to the drugs.

Outlook: Lawsuits and safety concerns are expected to grow quickly as GLP-1 use spreads further into the mainstream.